Loading, please wait...
Date: Jun 19, 2025 08:00 AM - 09:00 AM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Jun 20, 2025 11:00 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants who attend the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.
Support/Credits
No commerical support.
Objectives
- o Identify common risk factors and vulnerable patient populations associated with SSRI-induced hyponatremia.
- o Describe the pathophysiological mechanisms, including SIADH, involved in SSRI-associated hyponatremia.
- o Recognize the clinical manifestations and diagnostic criteria of hyponatremia in patients on SSRI therapy.
- o Apply evidence-based approaches for the prevention, monitoring, and management of SSRI-induced hyponatremia in clinical practice.
Speaker(s)/Author(s)
|
Yanise Hurt, PharmD
|
Activity Number
0483-0000-25-012-L01-P
Date:
06/19/25
Time:
08:00 AM - 09:00 AM
CE Hours
1.00
Location
via MS Teams and KH
Objectives
- o Identify common risk factors and vulnerable patient populations associated with SSRI-induced hyponatremia.
- o Describe the pathophysiological mechanisms, including SIADH, involved in SSRI-associated hyponatremia.
Speaker(s)/Author(s)
|
Yanise Hurt, PharmD
|
Activity Number
0483-0000-25-012-L01-T
Date:
06/19/25
Time:
08:00 AM - 09:00 AM
CE Hours
1.00
Location
via MS Teams and KH